|1.||Poulter, Neil R: 1 article (12/2011)|
|2.||Aalbers, J: 1 article (03/2010)|
|3.||Dolan, Eamon: 1 article (04/2009)|
|4.||ASCOT Investigators: 1 article (04/2009)|
|5.||Scheen, A J: 1 article (04/2009)|
|6.||Collier, David: 1 article (04/2009)|
|7.||Stanton, Alice V: 1 article (04/2009)|
|8.||Caulfield, Mark: 1 article (04/2009)|
|9.||Atkins, Neil: 1 article (04/2009)|
|10.||Dicker, Patrick: 1 article (04/2009)|
01/01/2006 - "The ASCOT trial showed that in primary prevention of hypotensive patients with more than 3 associated cardiovascular risk factors, a strategy based on amlodipine secondarily associated with a diuretic, provided better control of the blood pressure than that of a betablocker secondarily associated with a diuretic: the therapeutic trial was negative with respect to the primary criterion including fatal coronary events and non-fatal myocardial infarction but the trial was stopped prematurely because of a significant reduction in cardiovascular and global mortality in the amlodipine-perindopril arm compared with the atenolol-thiazide arm. "
01/01/2000 - "The Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) compares the effects of amlodipine +/- perindopril with atenolol +/- bendrofluazide on fatal coronary artery disease and nonfatal myocardial infarction in 18,000 high risk patients. "
03/01/2010 - "Reduced blood pressure variability in ASCOT-BPLA trial favours use of amlodipine/perindopril combination to reduce stroke risk."
03/01/2010 - "Lower within-individual visit-to-visit variability in blood pressure readings in the amlodipine/perindopril combination treatment arm of the ASCOT study has been shown to account for the more effective stroke reduction rate with this combination compared to atenolol and diuretic-based therapies, despite overall similar blood pressure lowering."
04/01/2009 - "Results of the Anglo-Scandinavian cardiac outcomes trial-blood pressure lowering arm (ASCOT-BPLA) showed significantly lower rates of coronary and stroke events in individuals allocated an amlodipine-perindopril combination drug regimen than in those allocated an atenolol-thiazide combination drug regimen. "
|3.||Coronary Artery Disease (Coronary Atherosclerosis)
|4.||Hypertension (High Blood Pressure)
|5.||Coronary Disease (Coronary Heart Disease)